A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This is a double-blinded, placebo controlled study of estriol pills versus placebo pills in
relapsing remitting multiple sclerosis. The study treatment will be an added on to Copaxone
injections in all subjects. The primary outcome measure is a reduction in relapses.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
Dartmouth-Hitchcock Medical Center Johns Hopkins University Mayo Clinic National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH) National Multiple Sclerosis Society Ohio State University University of Chicago University of Colorado, Aurora University of Colorado, Denver University of Kansas Medical Center University of Medicine and Dentistry of New Jersey University of Minnesota University of Minnesota, MN University of New Mexico University of Pennsylvania University of Texas Southwestern Medical Center University of Utah Washington University School of Medicine